NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa Cells

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 4, 2014, Pages 344-354

  Zhou, Fei ^a   Wang, Wei ^a   Xing, Yujun ^a,b   Wang, Tingting ^a   Xu, Xinhui ^a   Wang, Jinke ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

HeLa cell; MiRNA; NF B; Target gene; TNF

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 125B; MICRORNA 1276; MICRORNA 1286; MICRORNA 2467 5P; MICRORNA 291 1-3P; MICRORNA 30B 3P; MICRORNA 3200 3P; MICRORNA 340 3P; MICRORNA 3620 5P; MICRORNA 4454; MICRORNA 4485; MICRORNA 449C 5P; MICRORNA 502 5P; MICRORNA 548D 5P; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LUNG CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING; RNA ANALYSIS; RNA SEQUENCE;

HELA CELL; MIRNA; NF-ΚB; TARGET GENE; TNFΑ;

GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HEP G2 CELLS; HUMANS; MICRORNAS; NEOPLASMS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896955457     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.01.006     Document Type: Article

References (57)

1. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986, 46:705-716.
2. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
3. Ma X., Becker Buscaglia L.E., Barker J.R., Li Y. MicroRNAs in NF-kappaB signaling. J. Mol. Cell Biol. 2011, 3:159-166.
4. Xing Y., Zhou F., Wang J. Subset of genes targeted by transcription factor NF-kappaB in TNFalpha-stimulated human HeLa cells. Funct. Integr. Genomics. 2013, 13:143-154.
5. Hayden M.S., Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
6. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
7. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
8. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 13:1097-1101.
9. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 2004, 432:231-235.
10. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293:834-838.
11. Grishok A., Pasquinelli A.E., Conte D., Li N., Parrish S., Ha I., Baillie D.L., Fire A., Ruvkun G., Mello C.C. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001, 106:23-34.
12. Schwarz D.S., Hutvagner G., Du T., Xu Z., Aronin N., Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115:199-208.
13. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
14. Zhou R., Hu G., Gong A.Y., Chen X.M. Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res. 2010, 38:3222-3232.
15. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
16. Tili E., Michaille J.J., Cimino A., Costinean S., Dumitru C.D., Adair B., Fabbri M., Alder H., Liu C.G., Calin G.A., Croce C.M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 2007, 179:5082-5089.
17. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12481-12486.
18. Zhou R., Hu G., Liu J., Gong A.Y., Drescher K.M., Chen X.M. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PloS Pathog. 2009, 5:e1000681.
19. Ning Z., Cox A.J., Mullikin J.C. SSAHA: a fast search method for large DNA databases. Genome Res. 2001, 11:1725-1729.
20. Lim C.A., Yao F., Wong J.J., George J., Xu H., Chiu K.P., Sung W.K., Lipovich L., Vega V.B., Chen J., Shahab A., Zhao X.D., Hibberd M., Wei C.L., Lim B., Ng H.H., Ruan Y., Chin K.C. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol. Cell 2007, 27:622-635.
21. Antonaki A., Demetriades C., Polyzos A., Banos A., Vatsellas G., Lavigne M.D., Apostolou E., Mantouvalou E., Papadopoulou D., Mosialos G., Thanos D. Genomic analysis reveals a novel nuclear factor-kappaB (NF-kappaB)-binding site in Alu-repetitive elements. J. Biol. Chem. 2011, 286:38768-38782.
22. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., Rinn J.L., Nelson F.K., Miller P., Gerstein M., Weissman S., Snyder M. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12247-12252.
23. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., Kloos D.U., Land S., Lewicki-Potapov B., Michael H., Munch R., Reuter I., Rotert S., Saxel H., Scheer M., Thiele S., Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003, 31:374-378.
24. Nijnik A., Mott R., Kwiatkowski D.P., Udalova I.A. Comparing the fine specificity of DNA binding by NF-kappaB p50 and p52 using principal coordinates analysis. Nucleic Acids Res. 2003, 31:1497-1501.
25. Lim C.A., Yao F., Wong J.J., George J., Xu H., Chiu K.P., Sung W.K., Lipovich L., Vega V.B., Chen J., Shahab A., Zhao X.D., Hibberd M., Wei C.L., Lim B., Ng H.H., Ruan Y., Chin K.C. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol. Cell 2007, 27:622-635.
26. Wong D., Teixeira A., Oikonomopoulos S., Humburg P., Lone I.N., Saliba D., Siggers T., Bulyk M., Angelov D., Dimitrov S., Udalova I.A., Ragoussis J. Extensive characterization of NF-kappaB binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits. Genome Biol. 2011, 12:R70.
27. Settembre C., De Cegli R., Mansueto G., Saha P.K., Vetrini F., Visvikis O., Huynh T., Carissimo A., Palmer D., Klisch T.J., Wollenberg A.C., Di Bernardo D., Chan L., Irazoqui J.E., Ballabio A. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 2013, 15:647-658.
28. Mukhopadhyay A., Deplancke B., Walhout A.J., Tissenbaum H.A. Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans. Nat. Protoc. 2008, 3:698-709.
29. Nishida J., Li Y., Zhuang Y., Huang Z., Huang H. IFN-gamma suppresses permissive chromatin remodeling in the regulatory region of the Il4 gene. Cytokine 2013, 62:91-95.
30. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
31. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 2011, 44:839-847.
32. Reczko M., Maragkakis M., Alexiou P., Grosse I., Hatzigeorgiou A.G. Functional microRNA targets in protein coding sequences. Bioinformatics 2012, 28:771-776.
33. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
34. Kerr M.K., Martin M., Churchill G.A. Analysis of variance for gene expression microarray data. J. Comput. Biol.s 2000, 7:819-837.
35. Sun Y., Zhao X., Zhou Y., Hu Y. miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect. Oncol. Rep. 2012, 28:1346-1352.
36. Wu Z.S., Wu Q., Wang C.Q., Wang X.N., Huang J., Zhao J.J., Mao S.S., Zhang G.H., Xu X.C., Zhang N. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer 2011, 117:2842-2852.
37. Heyn H., Schreek S., Buurman R., Focken T., Schlegelberger B., Beger C. MicroRNA miR-548d is a superior regulator in pancreatic cancer. Pancreas 2012, 41:218-221.
38. Hummel R., Wang T., Watson D.I., Michael M.Z., Van der Hoek M., Haier J., Hussey D.J. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol. Rep. 2011, 26:1011-1017.
39. Zhang Y., Yan L.X., Wu Q.N., Du Z.M., Chen J., Liao D.Z., Huang M.Y., Hou J.H., Wu Q.L., Zeng M.S., Huang W.L., Zeng Y.X., Shao J.Y. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res. 2011, 71:3552-3562.
40. Nakanishi H., Taccioli C., Palatini J., Fernandez-Cymering C., Cui R., Kim T., Volinia S., Croce C.M. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Oncogene 2013, 10.1038/onc.2013.13.
41. Enomoto Y., Kitaura J., Shimanuki M., Kato N., Nishimura K., Takahashi M., Nakakuma H., Kitamura T., Sonoki T. MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPalpha (C/EBPalpha-C(m))-induced myeloid leukemia. Int. J. Hematol. 2012, 96:334-341.
42. Yamashiro S., Yamakita Y., Totsukawa G., Goto H., Kaibuchi K., Ito M., Hartshorne D.J., Matsumura F. Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1. Dev. Cell 2008, 14:787-797.
43. Wu Y., Muranyi A., Erdodi F., Hartshorne D.J. Localization of myosin phosphatase target subunit and its mutants. J. Muscle Res. Cell Motil. 2005, 26:123-134.
44. Lukiw W.J. NF-small ka, CyrillicB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp. Neurol. 2012, 235:484-490.
45. Tan G., Niu J., Shi Y., Ouyang H., Wu Z.H. NF-kappaB-dependent microRNA-125b up-regulation promotes cell survival by targeting p38alpha upon ultraviolet radiation. Int. J. Biol. Chem. 2012, 287:33036-33047.
46. Zhou M., Liu Z., Zhao Y., Ding Y., Liu H., Xi Y., Xiong W., Li G., Lu J., Fodstad O., Riker A.I., Tan M. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. Int. J. Biol. Chem. 2010, 285:21496-21507.
47. Kim S.W., Ramasamy K., Bouamar H., Lin A.P., Jiang D., Aguiar R.C. MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc. Natl. Acad. Sci. U. S. A. 2012, 109:7865-7870.
48. Krikos A., Laherty C.D., Dixit V.M. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J. Biol. Chem. 1992, 267:17971-17976.
49. Vereecke L., Beyaert R., van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009, 30:383-391.
50. Honma K., Tsuzuki S., Nakagawa M., Karnan S., Aizawa Y., Kim W.S., Kim Y.D., Ko Y.H., Seto M. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosom. Cancer 2008, 47:1-7.
51. DiDonato J.A., Mercurio F., Karin M. NF-kappaB and the link between inflammation and cancer. Immunol. Rev. 2012, 246:379-400.
52. Papathanasiou I., Malizos K.N., Tsezou A. Bone morphogenetic protein-2-induced Wnt/beta-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes. Arthritis Res. Ther. 2012, 14:R82.
53. Anderson E.J., Rodriguez E., Anderson C.A., Thayne K., Chitwood W.R., Kypson A.P. Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H118-H124.
54. Feng J., Liu Y., Dobrilovic N., Chu L.M., Bianchi C., Singh A.K., Sellke F.W. Altered apoptosis-related signaling after cardioplegic arrest in patients with uncontrolled type 2 diabetes mellitus. Circulation 2013, 128:S144-S151.
55. Blank J.L., Gerwins P., Elliott E.M., Sather S., Johnson G.L. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J. Biol. Chem. 1996, 271:5361-5368.
56. Filion C., Labelle Y. Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma. Tumour Biol. 2012, 33:1599-1605.
57. Sun Y.M., Lin K.Y., Chen Y.Q. Diverse functions of miR-125 family in different cell contexts. J. Hematol. Oncol. 2013, 6:6.